Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells

Journal of Leukocyte Biology

Volumn 94, Issue 4, 2013, Pages 733-749

  Kim, Jong Seok ^a   Kim, Woo Sik ^a,b   Choi, Han Gyu ^b   Jang, Byungki ^a   Lee, Keehoon ^a   Park, Jong Hwan ^c   Kim, Hwa Jung ^b   Cho, Sang Nae ^a   Shin, Sung Jae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c Konyang University   (South Korea)

Author keywords

GATA 3; T bet; Vaccine

Indexed keywords

B7 ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; CD86 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE; MYCOBACTERIUM TUBERCULOSIS RPFB PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FUNCTIONAL STATUS; IMMUNITY; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TH1 CELL;

GATA-3; T-BET; VACCINE;

ANIMALS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; ENDOTOXINS; ENZYME ACTIVATION; FEMALE; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYCOBACTERIUM TUBERCULOSIS; NEUTRALIZATION TESTS; NF-KAPPA B; PHENOTYPE; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TH1 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84884860727     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0912435     Document Type: Article

References (54)

1. Cosma, C. L., Sherman, D. R., Ramakrishnan, L. (2003) The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57, 641-676.
2. Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., Dye, C. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009-1021.
3. Doherty, T. M., Andersen, P. (2005) Vaccines for tuberculosis: novel concepts and recent progress. Clin. Microbiol. Rev. 18, 687-702.
4. Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., Andersen, P. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672-678.
5. Gowthaman, U., Singh, V., Zeng, W., Jain, S., Siddiqui, K. F., Chodisetti, S. B., Gurram, R. K., Parihar, P., Gupta, P., Gupta, U. D., Jackson, D. C., Agrewala, J. N. (2011) Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J. Infect. Dis. 204, 1328-1338.
6. Verreck, F. A., Vervenne, R. A., Kondova, I., van Kralingen, K. W., Remarque, E. J., Braskamp, G., van der Werff, N. M., Kersbergen, A., Ottenhoff, T. H., Heidt, P. J., Gilbert, S. C., Gicquel, B., Hill, A. V., Martin, C., McShane, H., Thomas, A. W. (2009) MVA. 85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One 4, e5264.
7. Frigui, W., Bottai, D., Majlessi, L., Monot, M., Josselin, E., Brodin, P., Garnier, T., Gicquel, B., Martin, C., Leclerc, C., Cole, S. T., Brosch, R. (2008) Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog. 4, e33.
8. Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., Dos Santos, S., Duthoy, S., Lacroix, C., Garcia-Pelayo, C., Inwald, J. K., Golby, P., Garcia, J. N., Hewinson, R. G., Behr, M. A., Quail, M. A., Churcher, C., Barrell, B. G., Parkhill, J., Cole, S. T. (2007) Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci. USA 104, 5596-5601.
9. Martin, C., Williams, A., Hernandez-Pando, R., Cardona, P. J., Gormley, E., Bordat, Y., Soto, C. Y., Clark, S. O., Hatch, G. J., Aguilar, D., Ausina, V., Gicquel, B. (2006) The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24, 3408-3419.
10. Kipnis, A., Irwin, S., Izzo, A. A., Basaraba, R. J., Orme, I. M. (2005) Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 Ligandhi population. Infect. Immun. 73, 7759-7764.
11. Campos, M., Godson, D. L. (2003) The effectiveness and limitations of immune memory: understanding protective immune responses. Int. J. Parasitol. 33, 655-661.
12. Ahmed, R., Gray, D. (1996) Immunological memory and protective immunity: understanding their relation. Science 272, 54-60.
13. Singh, V., Jain, S., Gowthaman, U., Parihar, P., Gupta, P., Gupta, U. D., Agrewala, J. N. (2011) Co-administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCG. PLoS One 6, e16097.
14. Flynn, J. L., Chan, J. (2001) Tuberculosis: latency and reactivation. Infect. Immun. 69, 4195-4201.
15. Tufariello, J. M., Mi, K., Xu, J., Manabe, Y. C., Kesavan, A. K., Drumm, J., Tanaka, K., Jacobs, W. R., Jr., Chan, J. (2006) Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect. Immun. 74, 2985-2995.
16. Romano, M., Aryan, E., Korf, H., Bruffaerts, N., Franken, C. L., Ottenhoff, T. H., Huygen, K. (2012) Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. Microbes Infect. 14, 86-95.
17. Yeremeev, V. V., Kondratieva, T. K., Rubakova, E. I., Petrovskaya, S. N., Kazarian, K. A., Telkov, M. V., Biketov, S. F., Kaprelyants, A. S., Apt, A. S. (2003) Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice. Infect. Immun. 71, 4789-4794.
18. Mukamolova, G. V., Turapov, O. A., Young, D. I., Kaprelyants, A. S., Kell, D. B., Young, M. (2002) A family of autocrine growth factors in Mycobacterium tuberculosis. Mol. Microbiol. 46, 623-635.
19. Cole, S.T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry III, C. E., Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., Hornsby, T., Jagels, K., Krogh, A., McLean, J., Moule, S., Murphy, L., Oliver, K., Osborne, J., Quail, M. A., Rajandream, M. A., Rogers, J., Rutter, S., Seeger, K., Skelton, J., Squares, R., Squares, S., Sulston, J. E., Taylor, K., Whitehead, S., Barrell, B. G. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
20. Mukamolova, G. V., Kaprelyants, A. S., Kell, D. B. (1995) Secretion of an antibacterial factor during resuscitation of dormant cells in Micrococcus luteus cultures held in an extended stationary phase. Antonie Van Leeuwenhoek 67, 289-295.
21. Mukamolova, G. V., Yanopolskaya, N. D., Kell, D. B., Kaprelyants, A. S. (1998) On resuscitation from the dormant state of Micrococcus luteus. Antonie Van Leeuwenhoek 73, 237-243.
22. Russell-Goldman, E., Xu, J., Wang, X., Chan, J., Tufariello, J. M. (2008) A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 76, 4269-4281.
23. Zvi, A., Ariel, N., Fulkerson, J., Sadoff, J. C., Shafferman, A. (2008) Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med. Genomics 1, 18.
24. Redford, P. S., Murray, P. J., O'Garra, A. (2011) The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261-270.
25. Steinman, R. M., Inaba, K. (1999) Myeloid dendritic cells. J. Leukoc. Biol. 66, 205-208.
26. Reis e Sousa, C. (2001) Dendritic cells as sensors of infection. Immunity 14, 495-498.
27. Takeda, K., Akira, S. (2005) Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14.
28. Mukhopadhyay, S., Balaji, K. N. (2011) The PE and PPE proteins of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 91, 441-447.
29. Narayana, Y., Joshi, B., Katoch, V. M., Mishra, K. C., Balaji, K. N. (2007) Differential B-cell responses are induced by Mycobacterium tuberculosis PE antigens Rv1169c, Rv0978c, and Rv1818c. Clin. Vaccine Immunol. 14, 1334-1341.
30. Bansal, K., Elluru, S. R., Narayana, Y., Chaturvedi, R., Patil, S. A., Kaveri, S. V., Bayry, J., Balaji, K. N. (2010) PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J. Immunol. 184, 3495-3504.
31. Byun, E. H., Kim, W. S., Kim, J. S., Jung, I. D., Park, Y. M., Kim, H. J., Cho, S. N., Shin, S. J. (2012) Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response. FASEB J. 26, 2695-2711.
32. McKenna, K., Beignon, A. S., Bhardwaj, N. (2005) Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79, 17-27.
33. Phyu, S., Mustafa, T., Hofstad, T., Nilsen, R., Fosse, R., Bjune, G. (1998) A mouse model for latent tuberculosis. Scand. J. Infect. Dis. 30, 59-68.
34. Byun, E. H., Kim, W. S., Shin, A. R., Kim, J. S., Whang, J., Won, C. J., Choi, Y., Kim, S. Y., Koh, W. J., Kim, H. J., Shin, S. J. (2012) Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses. J. Mol. Med. (Berl.) 90, 285-298.
35. Moser, M., Murphy, K. M. (2000) Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1, 199-205.
36. Sallusto, F., Mackay, C. R., Lanzavecchia, A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620.
37. Andersen, P. (2001) TB vaccines: progress and problems. Trends Immunol. 22, 160-168.
38. Sharma, N., Agrewala, J. N. (2004) Potent role of vaccines prepared from macrophages infected with live bacteria in protection against Mycobacterium tuberculosis and Salmonella typhimurium infections. J. Infect. Dis. 190, 107-114.
39. Schuck, S. D., Mueller, H., Kunitz, F., Neher, A., Hoffmann, H., Franken, K. L., Repsilber, D., Ottenhoff, T. H., Kaufmann, S. H., Jacobsen, M. (2009) Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One 4, e5590.
40. Rogerson, B. J., Jung, Y. J., LaCourse, R., Ryan, L., Enright, N., North, R. J. (2006) Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology 118, 195-201.
41. Winslow, G. M., Roberts, A. D., Blackman, M. A., Woodland, D. L. (2003) Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170, 2046-2052.
42. Reiley, W. W., Shafiani, S., Wittmer, S. T., Tucker-Heard, G., Moon, J. J., Jenkins, M. K., Urdahl, K. B., Winslow, G. M., Woodland, D. L. (2010) Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 107, 19408-19413.
43. Jeon, B. Y., Kim, S. C., Eum, S. Y., Cho, S. N. (2011) The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. Microbes Infect. 13, 284-290.
44. Shi, C., Chen, L., Chen, Z., Zhang, Y., Zhou, Z., Lu, J., Fu, R., Wang, C., Fang, Z., Fan, X. (2010) Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 28, 5237-5244.
45. Urdahl, K. B., Shafiani, S., Ernst, J. D. (2011) Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 4, 288-293.
46. Biketov, S., Potapov, V., Ganina, E., Downing, K., Kana, B. D., Kaprelyants, A. (2007) The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice. BMC Infect. Dis. 7, 146.
47. Bansal, K., Sinha, A. Y., Ghorpade, D. S., Togarsimalemath, S. K., Patil, S. A., Kaveri, S. V., Balaji, K. N., Bayry, J. (2010) Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-κB signaling and drives Th2 immune responses. J. Biol. Chem. 285, 36511-36522.
48. Diebold, S. S. (2008) Determination of T-cell fate by dendritic cells. Immunol. Cell Biol. 86, 389-397.
49. Chakir, H., Wang, H., Lefebvre, D. E., Webb, J., Scott, F. W. (2003) Tbet/ GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J. Immunol. Methods 278, 157-169.
50. Wille-Reece, U., Flynn, B. J., Lore, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., Seder, R. A. (2006) Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203, 1249-1258.
51. Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., Fenton, M. J. (1999) Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163, 3920-3927.
52. Underhill, D. M., Ozinsky, A., Smith, K. D., Aderem, A. (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96, 14459-14463.
53. Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock, D. T., Vogel, S. N., Fenton, M. J. (2001) Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosisinduced macrophage responses. J. Immunol. 166, 4074-4082.
54. Jung, I. D., Jeong, S. K., Lee, C. M., Noh, K. T., Heo, D. R., Shin, Y. K., Yun, C. H., Koh, W. J., Akira, S., Whang, J., Kim, H. J., Park, W. S., Shin, S. J., Park, Y. M. (2011) Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparinbinding hemagglutinin, a novel TLR4 agonist. Cancer Res. 71, 2858-2870.